Found 7 matching trials
OLIGO-10: Stereotactic Ablative Radiation Therapy for Metastatic Patients With 6 to 10 Metastatic Sites PHASE2 Currently, the standard of care for patients with diagnosed metastatic canc...
Show More Location
A. Tsyb Medical Radiological Research Center
Learn More & Join Trial
Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care PHASE2 Currently, the usual standard of palliative treatment used in patients with...
Show More Location
A. Tsyb Medical Radiological Research Center
Learn More & Join Trial
Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma PHASE2 The purpose of this research is to evaluate the addition of radiotherapy to...
Show More Location
Westmead Hospital
Learn More & Join Trial
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of r...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction NA This is a multi-site single arm feasibility study of single-fraction Stereo...
Show More Location
Miami Cancer Institute at Baptist Health South Florida
Learn More & Join Trial
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease PHASE2 This study is being done to determine if stereotactic body radiotherapy (SB...
Show More Location
Natera, Inc. (Data and Specimen Analysis Only)
Learn More & Join Trial
Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM) PHASE1 To characterize feasibility, safety, and/or preliminary efficacy of persona...
Show More Location
Ut Southwestern Medical Center
Learn More & Join Trial